Both Ozempic for type 2 diabetes and the obesity treatment Wegovy have the same active ingredient, semaglutide.
Concerns over reports of suicidal ideation associated with semaglutide led to an investigation by the European Medicines Agency, while the U.S. Food and Drug Administration has listed suicidal ideation as a potential safety signal for GLP-1 drugs.
[
add
]
[
|
|
...
]